ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ClariVest Asset Management LLC 45,736$1,2280.07%
Wealth Architects, LLC 12,199$327,7870.06%
Rafferty Asset Management, LLC 297,755$8,000,6770.05%
Virtus ETF Advisers LLC 2,799$75,2090.05%
NJ State Employees Deferred Compensation Plan 10,500$282,1350.04%
CREDIT SUISSE AG/ 1,528,678$41,075,5760.04%
Candriam S.C.A. 220,054$5,912,8510.04%
BANQUE PICTET & CIE SA 131,699$3,538,7520.04%
Retirement Systems of Alabama 327,043$8,787,6450.04%
HoyleCohen, LLC 15,550$417,8290.04%
SG Americas Securities, LLC 128,440$3,4510.04%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 113,132$3,039,8570.04%
Ameritas Investment Partners, Inc. 34,227$919,6790.04%
Keystone Financial Group 8,000$214,9600.04%
Point72 Middle East FZE 39,245$1,054,5130.04%
Assenagon Asset Management S.A. 420,372$11,295,3960.04%
AMERICAN INTERNATIONAL GROUP, INC. 200,619$5,390,6330.04%
PANAGORA ASSET MANAGEMENT INC 207,093$5,564,5890.04%
Hudson Bay Capital Management LP 320,000$8,598,4000.03%
Elgethun Capital Management 4,000$105,2000.03%
External links

This page lists ARROWHEAD PHARMACEUTICALS IN's shareholders in Q3 2023. To view ARROWHEAD PHARMACEUTICALS IN's shareholder history, click here.